Table 5.
LVH | LVCG | Left Ventricular Geometry | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Concentric Remodelling (n =741) | Eccentric LVH (n =537) | Concentric LVH (n =238) | ||||||||
OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | |
Model 1 | ||||||||||
Arteriosclerosis | 1.417(1.184–1.696) | <0.001* | 1.332(1.134–1.564) | <0.001* | 1.359(1.131–1.634) | 0.001* | 1.477(1.193–1.829) | <0.001* | 1.880(1.378–2.563) | <0.001* |
Peripheral atherosclerosis | 1.345(1.058–1.709) | 0.015* | 1.505(1.214–1.865) | <0.001* | 1.524(1.179–1.968) | 0.001* | 1.376(1.020–1.855) | 0.036* | 2.016(1.392–2.920) | <0.001* |
Micro-albuminuria | 1.744(1.444–2.105) | <0.001* | 1.177(1.004–1.379) | 0.044* | 1.261(1.051–1.512) | 0.013* | 1.968(1.590–2.437) | <0.001* | 1.888(1.397–2.550) | <0.001* |
Decreased eGFR | 0.869(0.707–1.068) | 0.181 | 0.849(0.699–1.033) | 0.102 | 1.206(0.960–1.516) | 0.107* | 0.885(0.691–1.132) | 0.330 | 1.007(0.712–1.423) | 0.970 |
cIMT>0.9 or plaque | 0.929(0.777–1.111) | 0.419 | 1.017(0.864–1.197) | 0.839 | 1.050(0.869–1.267) | 0.615* | 0.947(0.765–1.173) | 0.617 | 0.889(0.661–1.196) | 0.436 |
Model 2 | ||||||||||
Arteriosclerosis | 1.343(1.112–1.622) | 0.002* | 1.290(1.090–1.528) | 0.003* | 1.320(1.088–1.602) | 0.005* | 1.406(1.125–1.759) | 0.003* | 1.731(1.253–2.393) | 0.001* |
Peripheral atherosclerosis | 1.376(1.070–1.770) | 0.013* | 1.526(1.219–1.910) | <0.001* | 1.583(1.211–2.069) | 0.001* | 1.440(1.054–1.968) | 0.022* | 2.019(1.370–2.976) | <0.001* |
Micro-albuminuria | 1.829(1.525–2.194) | <0.001* | 1.150(0.979–1.352) | 0.089 | 1.229(1.022–1.479) | 0.025* | 1.969(1.585–2.446) | <0.001* | 1.888(1.390–2.564) | <0.001* |
Model 3 | ||||||||||
Arteriosclerosis | 1.282(1.046–1.572) | 0.017* | 1.301(1.085–1.561) | 0.005* | 1.347(1.094–1.659) | 0.005* | 1.369(1.075–1.742) | 0.011* | 1.615(1.143–2.282) | 0.007* |
Peripheral atherosclerosis | 1.236(0.954–1.602) | 0.109 | 1.459(1.163–1.831) | 0.001* | 1.523(1.164–1.991) | 0.002* | 1.307(0.951–1.797) | 0.099 | 1.681(1.127–2.506) | 0.011* |
Micro-albuminuria | 1.690(1.398–2.043) | <0.001* | 1.170(0.991–1.382) | 0.064 | 1.243(1.028–1.504) | 0.025* | 1.812(1.446–2.270) | <0.001* | 1.783(1.299–2.447) | <0.001* |
Model 4 | ||||||||||
Arteriosclerosis | 1.291(1.044–1.598) | 0.019* | 1.271(1.051–1.537) | 0.013* | 1.329(1.069–1.651) | 0.010* | 1.393(1.083–1.791) | 0.010* | 1.577(1.104–2.254) | 0.012* |
Peripheral atherosclerosis | 1.276(0.973–1.673) | 0.078 | 1.515(1.197–1.918) | 0.001* | 1.603(1.215–2.116) | 0.001* | 1.346(0.967–1.874) | 0.079 | 1.704(1.129–2.573) | 0.011* |
Micro-albuminuria | 1.695(1.401–2.051) | <0.001* | 1.172(0.990–1.386) | 0.065 | 1.257(1.038–1.522) | 0.019* | 1.815(1.447–2.277) | <0.001* | 1.812(1.320–2.489) | <0.001* |
Notes: Multivariate logistic regressions were conducted to detect the regression coefficients and odds ratios (ORs) of vascular ageing parameters in LVH/LVCG, and 3 abnormal LV geometry. Model 1: adjusted for age and gender, respectively. Model 2: adjusted for age and gender, then vascular ageing parameters were incorporated in the model. Model 3: adjusted for conventional cardiovascular risk factors and diseases and treatments, respectively. Model 4: adjusted for conventional cardiovascular risk factors and diseases and treatments, then vascular ageing parameters were incorporated in the model. *P<0.05.
Abbreviations: LVH, left ventricular hypertrophy; LVCG, left ventricular concentric geometry, eGFR, estimated glomerular filtration rate; cIMT, carotid artery intima-media thickness.